Oyibo W A, Fagenro-Beyioku A F
Department of Medical Microbiology and Parasitology, College of Medicine, University of Lagos, Nigeria.
Southeast Asian J Trop Med Public Health. 2002 Sep;33(3):496-503.
Community acceptance of and compliance with annual ivermectin treatment in Shao, a sub-urban community in Kwara State, Nigeria, were remarkably high. Of 890 subjects from 204 randomly selected households, 832 (93.5%) had taken ivermectin at least once during the six-year treatment period. An average community acceptance rate (ACAR) of 88.77% (range 85.4 - 91.9%) was recorded during this period; a community compliance rate (CCR) of 74.76% was recorded. Overt refusals, covert refusals and those excluded from treatment were low and insignificant (p > 0.05). The mean compliance age was 37.47 +/- 16.52 years. Of the subjects studied, 40.67% reported adverse reactions to ivermectin during the first round of treatment (Tx1); this number decreased significantly (p < 0.05) to 15.43% during the sixth round of treatment (Tx6). Though considerable adverse reactions were reported in the community, these did not seem to have negatively affected acceptance of and compliance with annual ivermectin treatment; in some cases, the adverse reactions were believed by the villagers to demonstrate the efficacy and effectiveness of the drug. The community showed great awareness of the disease, its treatment with ivermectin and the distribution of the drug. On the basis of the high acceptance and compliance rates, it was concluded that Shao will benefit greatly from the current African Program for Onchocerciasis Control Strategy: Community-Directed Treatment with Ivermectin (CDTI) using Community-Directed Distributors (CDDs).
在尼日利亚夸拉州的一个城郊社区绍奥,社区对每年一次的伊维菌素治疗的接受度和依从性非常高。在从204个随机选择的家庭中抽取的890名受试者中,832人(93.5%)在六年的治疗期内至少服用过一次伊维菌素。在此期间记录的平均社区接受率(ACAR)为88.77%(范围85.4 - 91.9%);记录的社区依从率(CCR)为74.76%。公开拒绝、暗中拒绝以及被排除在治疗之外的情况很少且不显著(p > 0.05)。平均依从年龄为37.47 +/- 16.52岁。在所研究的受试者中,40.67%在第一轮治疗(Tx1)期间报告了对伊维菌素的不良反应;在第六轮治疗(Tx6)期间,这一数字显著下降(p < 0.05)至15.43%。尽管社区报告了相当多的不良反应,但这些似乎并未对每年一次的伊维菌素治疗的接受度和依从性产生负面影响;在某些情况下,村民们认为这些不良反应证明了该药物的疗效和有效性。该社区对疾病、其伊维菌素治疗以及药物分发表现出了很高的认知度。基于高接受率和依从率,得出的结论是,绍奥将从当前的非洲盘尾丝虫病控制计划战略:使用社区定向分发员(CDD)的社区定向伊维菌素治疗(CDTI)中大大受益。